Antitumor activity of the Epidermal Growth Factor Receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels

Barbara A. Helfrich, David Raben, Marileila Varella-Garcia, Dan Gustafson, Daniel C. Chan, Lynne Bemis, Chris Coldren, Anna Barón, Chan Zeng, Wilbur A. Franklin, Fred R. Hirsch, Adi Gazdar, John Minna, Paul A. Bunn

Research output: Contribution to journalArticlepeer-review

119 Scopus citations

Fingerprint

Dive into the research topics of 'Antitumor activity of the Epidermal Growth Factor Receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels'. Together they form a unique fingerprint.

Medicine & Life Sciences